Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $4,317,123.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $484.44 on Friday. The company has a market capitalization of $172.55 billion, a price-to-earnings ratio of 75.58, a PEG ratio of 5.85 and a beta of 1.43. The company’s 50 day simple moving average is $567.46 and its 200 day simple moving average is $531.26. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently bought and sold shares of ISRG. Howard Capital Management Group LLC increased its position in Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the last quarter. Principal Financial Group Inc. increased its position in Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after purchasing an additional 9,194 shares during the last quarter. Meritage Portfolio Management acquired a new position in Intuitive Surgical during the third quarter worth approximately $210,000. Venturi Wealth Management LLC increased its position in Intuitive Surgical by 166.5% during the third quarter. Venturi Wealth Management LLC now owns 1,351 shares of the medical equipment provider’s stock worth $664,000 after purchasing an additional 844 shares during the last quarter. Finally, Nations Financial Group Inc. IA ADV increased its position in Intuitive Surgical by 13.7% during the third quarter. Nations Financial Group Inc. IA ADV now owns 786 shares of the medical equipment provider’s stock worth $386,000 after purchasing an additional 95 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on ISRG shares. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. UBS Group boosted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.